Q&A 024 : Do I Need a Statin If I Feel Completely Fine?

⏱ 11 min read

Dr. Hayes Q&A · No. 024

By Eleanor Hayes, M.D. · Hospitalist

Starting a statin with no symptoms feels wrong to a lot of people, and it is one of the questions I hear most. If you feel completely fine, why begin a drug you may take for years? Here is how that decision actually gets made.

The Question

“A checkup showed my cholesterol was a bit high, and I was told to start a statin. But I have no symptoms and I feel completely fine. Do I really have to start a medication I might take for the rest of my life? Someone explained how much it lowers my relative risk, but the number never quite landed for me.”

— Name withheld

The Short Answer

Taking a statin with no symptoms is not the contradiction it feels like, because high cholesterol has no symptoms in the first place. The decision does not hinge on how you feel. It hinges on your absolute risk, not the relative-risk number that is so easy to quote and so hard to feel. For someone at low risk, the benefit is small. For someone at higher risk, it is real. To place you on that scale, the 2026 U.S. guideline uses a risk calculation called PREVENT. So the honest answer is that this is a decision made on your whole risk picture, not on a single cholesterol value and not on how well you feel today.

Why It’s Not That Simple

Start with the two ways risk gets described, because most of the confusion lives here. Relative risk is the one people quote: a statin might lower your risk of a cardiac event by something like a third. That sounds large. But a third of what? If your underlying risk is small, a third off a small number is a smaller number still. Absolute risk is what you actually feel in your life, and it is the one that should drive the decision.

The tool that makes this concrete is the number needed to treat, or NNT, which asks how many people have to take the drug to prevent one event. In a primary-prevention trial of people without known heart disease, the calculated numbers landed in a range that looked favorable next to older comparisons for blood pressure therapy or aspirin, but the point of the exercise was that the answer depends entirely on baseline risk. (number needed to treat with a statin in primary prevention, analysis) The same drug is a strong choice for one person and a marginal one for another, and the only thing that changes is where they started.

This is exactly why the field moved toward better risk estimation rather than treating a cholesterol number in isolation. The 2026 ACC/AHA dyslipidemia guideline replaced the older risk equations with the PREVENT equations, used to estimate both 10-year and 30-year risk in adults roughly 30 to 79 years old. Under that framework, lipid-lowering therapy is reasonable at a borderline 10-year estimate of 3 percent to under 5 percent, and recommended at an intermediate estimate of 5 percent to under 10 percent after a clinician-patient discussion. (2026 ACC/AHA guideline on the management of dyslipidemia) Your LDL of 165 is one input into that estimate. It is not, by itself, the whole decision.

And the honesty has to run both directions. A statin is not free of downsides. A minority of people have muscle complaints, and there is a small effect on blood sugar. For most people the benefit clearly outweighs the risk, but when someone’s baseline risk is genuinely low, that balance gets closer, which is the real reason the decision deserves a conversation rather than a reflex. (statins for primary prevention in low- and medium-risk patients, analysis)

Why Starting a Statin With No Symptoms Still Makes Sense

Here is the part that trips people up. A symptom is the body reporting a problem. Cholesterol does not file that report. Plaque builds along the artery walls quietly, over decades, and the first time many people learn it was there is the day it closes an artery. So waiting to feel something is waiting for the one event the whole effort is meant to prevent. That is the logic behind starting a statin with no symptoms: not because the drug is harmless, but because feeling fine was never evidence that the arteries were.

What I See in the Hospital

Two patterns, pulling in opposite directions. One is the person who started a statin, saw their numbers come back into range, and stopped taking it, treating a normal result as a cure. That misunderstanding is common enough that it deserves its own answer, which is coming later in this series. The other is the person who kept putting the decision off because nothing hurt, until the day something did. Neither pattern is about laziness. Both come from the same place: the belief that no symptoms means no problem. With cholesterol, that belief is simply wrong.

Plain-Language Reference

What to Actually Do

· Do not decline based on feeling fine. High cholesterol is symptomless by nature, so comfort tells you nothing about it.
· Ask your physician for your absolute 10-year, and now 30-year, risk estimate, not just a relative-risk percentage. That number is the one the decision should rest on.
· If your risk sits in a gray zone, a coronary calcium score can sharpen the picture. That is the subject of the next question in this series.
· Whether or not you start the drug, the groundwork still pays off: not smoking, blood pressure control, weight, and activity all lower risk on their own. A statin is added on top of that work, not a substitute for it.

So suppose you and your physician decide a statin makes sense. The very next question is the one people ask almost immediately: how low does the LDL actually need to go? That number is not the same for everyone either, and it is the next answer in this series.

This article is for general information only and does not constitute medical advice. Reading it creates no provider-patient relationship. Whether to start or continue any medication is a decision for you and a qualified licensed professional who knows your full history. Do not start, stop, or change a prescription based on this article.

Take care of yourself. Nobody else will do it for you.
— Eleanor Hayes, M.D.